Arsalan Arif founded Endpoints News to realize a vision of an independent journalism company covering the most critical developments for leaders across the biopharma world. Arsalan has cultivated a global team of writers and media pros to serve that core mission, now with over 30 full-time staff and counting whose work is seen daily by decision-makers who are changing the world of medicine. Since founding the company in 2016 with editor John Carroll, Arsalan and his team have attracted more than 125,000 subscribers spanning executive and scientific leadership at the top 25 pharma companies and thousands of biotech startups across the globe. His journalism duties include editing Endpoints' Early Edition and contributing news reports on cybersecurity and technology. Before founding Endpoints, Arsalan was the publisher of FierceBiotech and launched FiercePharma at FierceMarkets in Washington, DC. After growing his career in the nation's capital, he returned to his native Kansas and now lives with his family in Lawrence. Born and raised in Wichita — the aviation capital of the world — Arsalan has been a private pilot for 21 years. His parents emigrated from India, built small businesses in Kansas, and credits them for his education and entrepreneurial drive.
Sign up for free to read a limited number of articles each month.About You
Pick what newsletters get delivered to your inbox each week.
Want unlimited access? Sign up for a premium subscription plan.
Join over 182,500 biopharma colleagues who rely on Endpoints News every business day for the latest developments in drug discovery, development, and commercialization.